Summary
- Current Price
- As of today, PLX price is $2.07, down -3.05% in the most recent trading session on
- Current Price All-Time High
- PLX price is currently -99.77% below its historical high of $912.50 set on
- Market Cap
- PLX current market cap is $166M, down -26.41% year-over-year
- PE Ratio
- PLX PE ratio is unknown
- Revenue
- PLX current annual revenue is $52.74M, down -1.23% year-over-year
- Next Earnings
- The next earnings release for PLX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Protalix BioTherapeutics, Inc. |
| Ticker | NYSEAmerican: PLX |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | protalix.com |
| Employees | 213 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $2.07 | ||
| Price, 1D Change | -3.05% | |
| $166M | ||
| - | ||
| - | ||
| 1.41 | ||
| $53M | ||
| Revenue, 1Y Change | -1.23% | |
| -$0.08 | ||
| EPS, 1Y Change | -329.78% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | OTIX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.08 | ||
| EPS Estimate | N/A | $0.22 |
| EPS Est. Change | N/A | +355.65% |
| $52.74M | ||
| Revenue Estimate | N/A | $79.07M |
| Revenue Est. Change | N/A | +49.90% |
| $2.07 | ||
| Price Target | - | $11.00 |
| Price Tgt. Change | - | +432.69% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.04 | - | |
| -$0.01 | -$0.08 | -1,582.00% | |
| $0.22 | N/A | +355.65% | |
| $0.07 | N/A | +183.23% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $53.93M | $53.40M | -0.98% | |
| $57.98M | $52.74M | -9.03% | |
| $79.07M | N/A | +49.90% | |
| $69.05M | N/A | +30.91% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -27.29% | ||
| -36.85% | ||
| -26.41% | ||
| -22.22% | ||
| -1.23% | ||
| +10.72% | ||
| -329.78% | ||
| +72.69% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $2.07 | ||
| $2.10 | ||
| SMA 200 vs Price | +1.66% | |
| $2.43 | ||
| SMA 50 vs Price | +17.75% | |
| 1.41 | ||
| $0.08 | ||
| 40.09 | ||
| 24.35% | ||
| 80.44% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $52.74M | ||
| -$0.08 | ||
| $25.24M | ||
| 47.85% | ||
| -$5.50M | ||
| -10.43% | ||
| -$6.60M | ||
| -12.52% | ||
| -$4.04M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.17 | ||
| 2.51 | ||
| 1.54 | ||
| - | ||
| 1 | ||
| -2.61 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 3.15 | ||
| 3.45 | ||
| -35.62 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $48.23M | ||
| $30.98M | ||
| $82.35M | ||
| $66.67M | ||
| $34.12M | ||
| $26.52M | ||
| $8.32M | ||
| $1.38M | ||
| $5.26M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $59.35M | ||
| $31.25M | ||
| $27.51M | ||
| $0.00 | ||
| $1.47M | ||
| $0.00 | ||
| $996.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$11.99M | ||
| -$2.37M | ||
| $9.33M | ||
| $1.64M | ||
| -$13.63M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with PLX
FAQ
What is the ticker symbol for Protalix BioTherapeutics, Inc.?
The ticker symbol for Protalix BioTherapeutics, Inc. is NYSEAmerican:PLX
Does Protalix BioTherapeutics, Inc. pay dividends?
No, Protalix BioTherapeutics, Inc. does not pay dividends
What sector is Protalix BioTherapeutics, Inc. in?
Protalix BioTherapeutics, Inc. is in the Healthcare sector
What industry is Protalix BioTherapeutics, Inc. in?
Protalix BioTherapeutics, Inc. is in the Biotechnology industry
What country is Protalix BioTherapeutics, Inc. based in?
Protalix BioTherapeutics, Inc. is headquartered in United States
When did Protalix BioTherapeutics, Inc. go public?
Protalix BioTherapeutics, Inc. initial public offering (IPO) was on May 15, 1998
Is Protalix BioTherapeutics, Inc. in the S&P 500?
No, Protalix BioTherapeutics, Inc. is not included in the S&P 500 index
Is Protalix BioTherapeutics, Inc. in the NASDAQ 100?
No, Protalix BioTherapeutics, Inc. is not included in the NASDAQ 100 index
Is Protalix BioTherapeutics, Inc. in the Dow Jones?
No, Protalix BioTherapeutics, Inc. is not included in the Dow Jones index
When was Protalix BioTherapeutics, Inc. last earnings report?
Protalix BioTherapeutics, Inc.'s most recent earnings report was on November 13, 2025
When does Protalix BioTherapeutics, Inc. report earnings?
The next expected earnings date for Protalix BioTherapeutics, Inc. is May 8, 2026
Data Sources & References
- PLX Official Website www.protalix.com
- PLX Profile on Yahoo Finance finance.yahoo.com/quote/PLX
- PLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/plx